Valuation: Medpace Holdings, Inc.

Market Cap 1.77TCr 1.62TCr 1.5TCr 1.35TCr 2.54TCr 1,65600Cr 2.66TCr 18TCr 7.17TCr 89TCr 6.65TCr 6.51TCr 2,83500Cr P/E 2026 *
34.8x
P/E 2027 * 32.3x
Enterprise Value 1.69TCr 1.54TCr 1.43TCr 1.29TCr 2.42TCr 1,58000Cr 2.53TCr 17TCr 6.84TCr 85TCr 6.35TCr 6.22TCr 2,70500Cr EV / Sales 2026 *
5.94x
EV / Sales 2027 * 5.45x
Free-Float
81.13%
Yield 2026 *
-
Yield 2027 * -
1 day-1.99%
1 week-3.48%
Current month-2.77%
1 month+2.31%
3 months+4.23%
6 months+50.98%
Current year+12.88%
1 week 631.1
Extreme 631.1
659.99
1 month 614.98
Extreme 614.98
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%-3.48%+7.06%+131.37% 1.77TCr
+0.19%-3.96%+54.92%+69.15% 6.54TCr
-0.12%-2.35%+6.82%+90.33% 5.89TCr
-1.02%-0.48%+25.06%+85.55% 5.52TCr
-0.97%-3.91%+12.98%+113.88% 4.57TCr
-2.83%-7.58%+15.21%+22.34% 4.13TCr
+3.61%+2.63%+21.96%+46.39% 3.68TCr
-0.24%-9.59%+126.05%+647.44% 3.45TCr
-0.17%+1.25%+78.39%+57.25% 3.25TCr
+20.58%+22.35%-29.03%+482.03% 3.17TCr
Average +1.71%-0.70%+31.94%+174.57% 4TCr
Weighted average by Cap. +1.26%-1.08%+32.18%+152.94%

Financials

2026 *2027 *
Net sales 284.96Cr 259.63Cr 240.33Cr 217.39Cr 407.82Cr 27TCr 426.84Cr 2.91TCr 1.15TCr 14TCr 1.07TCr 1.05TCr 46TCr 302.13Cr 275.27Cr 254.82Cr 230.49Cr 432.39Cr 28TCr 452.56Cr 3.08TCr 1.22TCr 15TCr 1.13TCr 1.11TCr 48TCr
Net income 52Cr 47Cr 44Cr 40Cr 74Cr 4.86TCr 78Cr 530.68Cr 210.51Cr 2.63TCr 195.29Cr 191.2Cr 8.32TCr 55Cr 50Cr 47Cr 42Cr 79Cr 5.17TCr 83Cr 564.54Cr 223.94Cr 2.79TCr 207.75Cr 203.4Cr 8.85TCr
Net Debt -81Cr -74Cr -68Cr -62Cr -116.16Cr -7.58TCr -121.58Cr -827.49Cr -328.24Cr -4.1TCr -304.52Cr -298.14Cr -13TCr -127.23Cr -115.92Cr -107.3Cr -97Cr -182.08Cr -12TCr -190.57Cr -1.3TCr -514.5Cr -6.42TCr -477.31Cr -467.31Cr -20TCr
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
19/26/19 $633.98 -1.99% 1,67,804
18/26/18 $646.87 -0.95% 2,11,746
17/26/17 $653.09 +0.75% 1,80,226
16/26/16 $648.20 -0.88% 2,30,405
13/26/13 $653.94 -0.44% 1,05,452
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
633.98USD
Average target price
651.31USD
Spread / Average Target
+2.73%
  1. Stock Market
  2. Stocks
  3. MEDP Stock